The Gold Standard: Treating PH with Indomethacin
At a Glance
For paroxysmal hemicrania, indomethacin often stops attacks completely when the right dose is found, but long-term treatment requires the lowest effective dose, stomach protection, and monitoring of kidney function, blood pressure, and blood counts.
Indomethacin is more than just a treatment for Paroxysmal Hemicrania (PH); it is the “gold standard” therapy and a key part of confirming your diagnosis [1]. While most headaches might improve slightly with standard painkillers, PH is unique because it usually disappears completely when you are taking the right amount of indomethacin [2].
Before Starting Indomethacin
Because indomethacin is a potent systemic NSAID, it is critical that you never substitute, combine, or change doses on your own. Inform your prescriber immediately if you have any history of:
- Ulcers or GI bleeding
- Kidney disease or heart failure
- Uncontrolled blood pressure or cardiovascular disease
- Allergies to aspirin/NSAIDs (like asthma reactions)
- Pregnancy
- Other medications you take (such as blood thinners, corticosteroids, SSRIs, ACE-inhibitors/diuretics, lithium, methotrexate, or over-the-counter NSAIDs).
The Dosing Strategy: Finding Your “Floor”
The goal of PH treatment is to find the lowest clinically useful dose—the smallest amount of medication that keeps your headaches 100% controlled [3].
- Starting Out: Doctors often begin with a dose like 25 mg taken three times a day [4]. If the headaches do not stop, the dose may be increased gradually, sometimes up to 75 mg or 150 mg per day, until the “breaking point” is found where the attacks cease [5]. (These are specialist-guided examples only.)
- Maintenance: Once your headaches have been fully controlled for several months, your doctor may suggest a very slow “taper” to see if a lower dose can still keep the pain away [2]. Because PH can be a chronic condition, many people stay on a maintenance dose for a long time, but the dose is always kept as low as possible to minimize risks [3].
Protecting Your Stomach
The most significant limitation of indomethacin is that it is “gastrolesive,” meaning it can be very harsh on the lining of your stomach and intestines [6][7]. It can cause gastric ulcers (sores in the stomach lining) and serious internal bleeding [8].
To prevent this, it is standard practice to use gastroprotection—additional medication to help shield your digestive system [9].
- Proton Pump Inhibitors (PPIs): Medications like omeprazole or pantoprazole are frequently prescribed alongside indomethacin. Research shows that PPIs significantly reduce the risk of developing ulcers and upper-GI bleeding while taking NSAIDs [10][11]. However, they reduce—but do not completely eliminate—this risk.
- Alternative Options: In some cases, doctors may recommend misoprostol or H2-receptor antagonists (like famotidine), though standard-dose H2 blockers are often not equivalent to PPIs for preventing NSAID ulcers [12][10].
Note: Always take indomethacin with food or milk as directed to help reduce immediate stomach upset. This helps with discomfort but does not prevent serious internal bleeding. [7]
Monitoring and Other Side Effects
Because indomethacin affects systems throughout your body, regular check-ups with your doctor are required. Approximately 10% to 20% of patients may eventually need to stop the medication due to side effects [6]. Your schedule will be individualized, but often involves monitoring the following:
- Kidney Health: Indomethacin can reduce blood flow to the kidneys, leading to renal toxicity or impairment [6][13]. Your doctor will likely order periodic blood tests (like serum creatinine/eGFR) to monitor how well your kidneys are filtering [14].
- Blood Counts: Your clinician may check your CBC or hemoglobin to watch for anemia or hidden bleeding.
- Blood Pressure and Heart: This medication can cause a significant increase in blood pressure and may increase the risk of cardiovascular issues over time [15][16]. You should monitor your blood pressure at home or during clinic visits.
- Brain and Mood: Some people experience “neuropsychiatric” reactions, which can include feeling “foggy,” dizzy, or experiencing mood changes like depression or anxiety [6]. A rare but documented side effect is myoclonus (involuntary muscle jerks), which typically resolves once the medication is stopped [17].
Common questions in this guide
Why is indomethacin considered the standard treatment for paroxysmal hemicrania?
How is the right indomethacin dose found for PH?
Should I take stomach protection with indomethacin?
What monitoring is needed during long-term indomethacin treatment?
Who should tell their doctor before taking indomethacin for PH?
What side effects should I watch for while taking indomethacin?
What should I do if I miss an indomethacin dose and my headache returns?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Paroxysmal hemicrania.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is the lowest possible dose of indomethacin that will keep my symptoms under control?
- 2.Based on my medical history, which specific gastroprotective medication (like a PPI) should I take alongside indomethacin?
- 3.How often should we check my kidney function and blood pressure while I am on this medication?
- 4.What should I do if I forget a dose and my headache symptoms suddenly return?
- 5.If I eventually need to stop indomethacin, how should we taper the dose to avoid a 'rebound' of my headaches?
References
References (17)
- 1
Paroxysmal Hemicrania: An Update.
Paliwal VK, Uniyal R
Neurology India 2021; (69(Supplement)):S135-S143 doi:10.4103/0028-3886.315982.
PMID: 34003159 - 2
Paroxysmal Hemicrania.
Osman C, Bahra A
Annals of Indian Academy of Neurology 2018; (21(Suppl 1)):S16-S22 doi:10.4103/aian.AIAN_317_17.
PMID: 29720814 - 3
Indomethacin-Responsive Headache Disorders.
Goadsby PJ
Continuum (Minneapolis, Minn.) 2024; (30(2)):488-497 doi:10.1212/CON.0000000000001409.
PMID: 38568495 - 4
Menstruation-triggered paroxysmal hemicrania.
Patel S, Shah H, Prakash S
BMJ case reports 2026; (19(8)) doi:10.1136/bcr-2026-274651.
PMID: 42618320 - 5
Paroxysmal hemicrania: A diagnostic challenge presenting as orofacial pain: A case series.
Al-Taee A, Botros J, Groenke BR, Nixdorf DR
Cranio : the journal of craniomandibular practice 2026; (44(4)):721-728 doi:10.1080/08869634.2025.2610489.
PMID: 41456204 - 6
Lipid Formulations and Bioconjugation Strategies for Indomethacin Therapeutic Advances.
Gliszczyńska A, Nowaczyk M
Molecules (Basel, Switzerland) 2021; (26(6)) doi:10.3390/molecules26061576.
PMID: 33809343 - 7
How can you manage an indomethacin-responsive headache in someone who cannot take indomethacin?
Osiowski A, Stolarz K, Taterra D
Current opinion in neurology 2025; (38(3)):254-261 doi:10.1097/WCO.0000000000001347.
PMID: 39911098 - 8
Protective effects of Saccharomyces boulardii CNCM I-745 in an experimental model of NSAID-induced enteropathy.
Simon O'Brien E, Robert A, Gauthier D, et al.
Beneficial microbes 2023; (14(3)):239-253 doi:10.3920/BM2023.0003.
PMID: 37646075 - 9
Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations.
Szeto CC, Sugano K, Wang JG, et al.
Gut 2020; (69(4)):617-629 doi:10.1136/gutjnl-2019-319300.
PMID: 31937550 - 10
Proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug-induced ulcers and dyspepsia.
Garegnani L, Oltra G, Burgos MA, et al.
The Cochrane database of systematic reviews 2025; (5()):CD014585 doi:10.1002/14651858.CD014585.pub2.
PMID: 40337979 - 11
Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials.
Scally B, Emberson JR, Spata E, et al.
The lancet. Gastroenterology & hepatology 2018; (3(4)):231-241 doi:10.1016/S2468-1253(18)30037-2.
PMID: 29475806 - 12
Systematic review with network meta-analysis: comparative effectiveness and safety of strategies for preventing NSAID-associated gastrointestinal toxicity.
Yuan JQ, Tsoi KK, Yang M, et al.
Alimentary pharmacology & therapeutics 2016; (43(12)):1262-75 doi:10.1111/apt.13642.
PMID: 27121479 - 13
Use of non-steroidal anti-inflammatory drugs in renal transplant patients: A retrospective study.
Sridharan K, Shah S
The International journal of risk & safety in medicine 2023; (34(4)):379-386 doi:10.3233/JRS-220065.
PMID: 37154186 - 14
Incidence, risk and risk factors for acute kidney injury associated with the use of intravenous indomethacin in neonatal patent ductus arteriosus: A 16-year retrospective cohort study.
Raknoo T, Janjindamai W, Sitaruno S, et al.
Pharmacy practice 2021; (19(4)):2409 doi:10.18549/PharmPract.2021.4.2409.
PMID: 35474648 - 15
Indomethacin-Induced Hypertensive Crisis.
Dhungana B, Kansakar S, Paudel P, et al.
Cureus 2021; (13(9)):e18043 doi:10.7759/cureus.18043.
PMID: 34692276 - 16
Metabolomic Studies for Metabolic Alterations Induced by Non-Steroidal Anti-Inflammatory Drugs: Mini Review.
Ghosh S
Biomolecules 2021; (11(10)) doi:10.3390/biom11101456.
PMID: 34680089 - 17
Hemicrania continua: Indomethacin induced myoclonus.
Chan TLH, Hindiyeh N
Clinical neurology and neurosurgery 2021; (206()):106703 doi:10.1016/j.clineuro.2021.106703.
PMID: 34049752
This page explains indomethacin treatment and safety monitoring for paroxysmal hemicrania for educational purposes only and does not replace medical advice. Do not start, stop, combine, or change doses without guidance from your prescriber.